510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0304-2019Class II

Brilliance 64 (Model No. 728231), Software version 4.1.6

Philips North America LLC / initiated 2017-06-07 / Terminated / root cause: software

Philips Medical Systems (Cleveland) Inc began a recall of Brilliance 64 (Model No. 728231), Software version 4.1.6 Product Usage: Computed Tomography X-ray systems intended to produce cross-sectional Images of the... on . FDA classified it as Class II and gives the reason as "It was reported that scanners running certain software versions provide confusing information in the "Impressions" section of the Calcium Score report. The generated report provides multiple analyses of the amount of...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0304-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Philips North America LLC
Product
Brilliance 64 (Model No. 728231), Software version 4.1.6 Product Usage: Computed Tomography X-ray systems intended to produce cross-sectional Images of the body by computer reconstruction of X-ray transmission data taken at different angles and planes. These devices may include signal analysts and display equipment, patient and equipment supports, components, and accessories.
Product code
JAK System, X-Ray, Tomography, Computed
Reason for recall
It was reported that scanners running certain software versions provide confusing information in the "Impressions" section of the Calcium Score report. The generated report provides multiple analyses of the amount of plaque detected, as if they all apply to the patient at the same time. This misleading guidance can be potentially misleading to the user, and may lead to mistreatment of the patient.
Root cause tag
software
FDA root cause
Software design
Action
The recalling firm sent Customer Information letters dated June 7, 2017, to affected customers. The letter notified customers of the product issue. Customers were instructed to determine whether they had a potentially affected system by checking the software version of their device. Customers were reminded that the "Impressions" section of the report is not intended for diagnostic use. Users should instead focus on the total calcium score shown in the "Findings" section, the coronary artery score(s) and/or the "Age and Gender" graph as identified in the Instructions for Use (IFU). The firm sent a follow-up dated July 3, 2018, to inform customers that software updates had been released which resolved the issue. If you need any further information or support concerning this issue, please contact your local Philips representative: For North America and Canada, contact the Customer Care Solutions Center (1 -800-722-9377 and follow the prompts).
Quantity in commerce
1890
Distribution
US Nationwide Distribution
Product codes and lots
Software Version 4.1.6

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0304-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0303-2019Class IITerminatedVoluntary: Firm initiated
Z-0304-2019Class IITerminatedVoluntary: Firm initiated
Z-0305-2019Class IITerminatedVoluntary: Firm initiated
Z-0306-2019Class IITerminatedVoluntary: Firm initiated
Z-0307-2019Class IITerminatedVoluntary: Firm initiated
Z-0308-2019Class IITerminatedVoluntary: Firm initiated
Z-0309-2019Class IITerminatedVoluntary: Firm initiated
Z-0310-2019Class IITerminatedVoluntary: Firm initiated
Z-0311-2019Class IITerminatedVoluntary: Firm initiated